E-SHAP for refractory and relapsing lymphoma: influence of patient selection on response rate

Ann Oncol. 1993 Dec;4(10):896. doi: 10.1093/oxfordjournals.annonc.a058402.
No abstract available

Publication types

  • Letter
  • Review

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Follow-Up Studies
  • Hodgkin Disease / drug therapy*
  • Hodgkin Disease / mortality
  • Humans
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Lymphoma, Non-Hodgkin / mortality
  • Male
  • Prognosis
  • Survival Rate